Norbert W. Bischofberger, EVP, R&D and CSO at GILEAD SCIENCES INC (GILD), sold 70,000 shares at $109.12 ($7.7M) on 2015-05-15, disclosed to the SEC on 2015-05-19.
Scheduled sale ($7.7M) by EVP, R&D and CSO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $109.12 | 26,038 | $2.8M | 37.1% |
| 2 | $109.65 | 43,962 | $4.8M | 62.9% |
| Total | $109.45 avg | 70,000 | $7.7M | 100% |
| Filing → |
| KRON | BUY | 2023-11-17 | $2.7M | — | Filing → |
| KRON | BUY | 2022-05-19 | $3.4M | — | Filing → |
| KRON | BUY | 2021-12-08 | $347K | — | Filing → |